|
|
|||
|
| |||
|
| |||
|
| |||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Mehmet Aslan, Mehmet Horoz, Department of Internal Medicine, Faculty of Medicine, Harran University, Sanliurfa, Turkey Yasar Nazligul, Cengiz Bolukbas, F Fusun Bolukbas, Department of Gastroenterology, Faculty of Medicine, Harran University, Sanliurfa, Turkey Sahbettin Selek, Hakim Celik, Ozcan Erel, Department of Clinical Biochemistry, Faculty of Medicine, Harran University, Sanliurfa, Turkey Correspondence to: Dr. Mehmet Aslan, Department of Internal Medicine, Faculty of Medicine, Harran University, Bahcelievler Mah, Sema Apt A, Blok No. 8, Sanliurfa 63200, Turkey. m.aslan301@mynet.com Telephone: +90-414-3140216 Fax: +90-414-3140216 Received: 2006-04-04 Accepted: 2006-04-24
Abstract AIM: to determine the insulin resistance (IR) and oxidative status in H pylori infection and to find out if there is any relationship between these parameters and insulin resistance.
METHODS: Fifty-five H pylori positive and 48 H pylori negative patients were enrolled. The homeostasis model assessment (HOMA) was used to assess insulin resistance. Serum total antioxidant capacity (TAC), total oxidant status (TOS) and oxidative stress index (OSI) were determined in all subjects.
RESULTS: The total antioxidant capacity was significantly lower in H pylori positive group than in H pylori negative group (1.36 ± 0.33 and 1.70 ± 0.50, respectively; P < 0.001), while the total oxidant status and oxidative stress index were significantly higher in H pylori positive group than in H pylori negative group (6.79 ± 3.40 and 5.08 ± 0.95, and 5.42 ± 3.40 and 3.10 ± 0.92, respectively; P < 0.001). Insulin resistance was significantly higher in H pylori positive group than in H pylori negative group (6.92 ± 3.86 and 3.61 ± 1.67, respectively; P < 0.001). Insulin resistance was found to be significantly correlated with total antioxidant capacity (r = -0.251, P < 0.05), total oxidant status (r = 0.365, P < 0.05), and oxidative stress index (r = 0.267, P < 0.05).
CONCLUSION: Insulin resistance seems to be associated with increased oxidative stress in H pylori infection. Further studies are needed to clarify the mechanisms underlying this association and elucidate the effect of adding antioxidant vitamins to H pylori eradication therapy on insulin resistance during H pylori infection.
© 2006 The WJG Press. All rights reserved.
Key words: H pylori; Insulin resistance; Total antioxidant capacity; Total oxidant status; Oxidative stress index
Aslan M, Horoz M, Nazlıgul Y, Bolukbas C, Bolukbas FF, Selek S, Celik H, Erel O. Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol 2006; 12(42): 6865-6868 http://www.wjgnet.com/1007-9327/12/6865.asp
INTRODUCTION H pylori is a noninvasive, microaerophile, nonspore-forming, and spiral-shaped microorganism. H pylori is associated with severe gastric pathologies, including chronic active gastritis, peptic ulcer, gastric adenocarci-noma and type B low-grade mucosa-associated lymphoid tissue lymphoma[1]. H pylori infection causes inflammation, accumulation of reactive oxygen species (ROS), and oxidative DNA damage in gastric mucosa[1]. H pylori induces infiltration and activation of neutrophils and macrophages[2]. One characteristic event in inflammation is the infiltration of the affected tissue by neutrophils, which produce large amounts of ROS in host defence reactions. Enhanced ROS levels due to neutrophil infiltration and increased oxidative DNA damage have been reported in H pylori-infected patients[3-6]. The increased level of pro-oxidative factors and decreased level of antioxidants in severe oxidative stress can modulate many processes in gastric epithelium[2]. Although H pylori seems to be a cause for gastric focal inflammation, it can invade and colonize human stomach, and directly interact with gastric epithelial cells. Moreover, it is associated with non-gastrointestinal tract conditions such as atherosclerosis, insulin resistance, diabetes mellitus and some autoimmune diseases[1,7-9]. The association of H pylori infection with insulin resistance has been reported[10-12]. However, to our knowledge, the association between insulin resistance and oxidative status has not been previously investigated in H pylori infection. The present study was, therefore, to determine the insulin resistance, systemic parameters of oxidative stress and antioxidative system in H pylori infection and to find out if there is any relationship between oxidative status and insulin resistance in H pylori infection.
MATERIALS AND METHODS Subjects One hundred and three patients who underwent upper gastrointestinal endoscopy for evaluation of dyspeptic complaints and diagnosed as non ulcer dyspepsia were included in the present study. The patients were divided into two groups according to the presence of H pylori infection. Fifty-five patients were H pylori positive and 48 patients were H pylori negative. The study protocol was carried out in accordance with the Helsinki Declaration revised in 1989. All subjects were informed about the study protocol and written consents were obtained from all participants.
Diagnosis of H pylori infection During upper gastrointestinal endoscopy, 2 antral biopsy samples were taken for rapid urease test (CLO test) and histopathologic examination. H pylori was considered to be present when the rapid urease test and histological examination were positive. Biopsy samplesl were stained with hematoxylin and eosin for histopathological examination and evaluated according to the updated Sydney System[13]. The patient was considered to be H pylori negative if both rapid urease test and histological examination were negative. The diagnosis of H pylori infection was confirmed if both the urease test and histological examination were positive.
Exclusion criteria Exclusion criteria included recent gastrointestinal by-pass surgery, pregnancy, usage of supplemental vitamins several months prior to the study, H pylori eradication therapy, H2 receptor antogonist or proton pump inhibitor within the last 4 wk or nonsteroidal antiinflammatory drugs (NSAIDs) within the last 2 wk prior to study, existence of diabetes mellitus, hyperlipidemia, hypertension, coronary artery disease, cerebrovascular disease, rheumatoid arthritis, renal disease, smoking, cancer, systemic or local infection.
Samples Blood samples were obtained following an overnight fasting. Samples were withdrawn from a cubital vein into blood tubes and immediately stored on ice at 4℃. The serum was then separated from the cells by centrifugation at 3000 r/min for 10 min.
Laboratory methods Serum glucose concentration was measured using commercial kits (Abbott®) in an autoanalyser (Aeroset®, Germany). Serum insulin levels were measured using an automated chemiluminescence autoanalyzer (Roche®).
Measurement of serum total antioxidantc capacity Total antioxidant capacity (TAC) of serum was determined using a novel automated measurement method as previously described[14]. In brief, hydroxyl radical which is the most potentbiological radical was produced. In the assay, ferrous ion solution which is present in the reagent 1 was mixed with hydrogen peroxide which is present in reagent 2. The sequential-produced radicals, such as brown-colored dianisidinyl radical cation produced by the hydroxyl radical, are also potent radicals. Using this method, antioxidative effect of the sample on the potent free radical reactions initiated by the produced hydroxyl radical, was determined. The assay achieved excellent precision values lower than 3%. The results were expressed as mmol Trolox equivalent/L.
Measurement of total oxidant status Total oxidant status (TOS) of serum was determined using a novel automated measurement method as previously described[15]. Oxidants present in the sample oxidized the ferrous ion-o-dianisidine complex to ferric ion. The oxidation reaction was enhanced by glycerol molecules abundantly present in the reaction medium. The ferric ion produced a colored complex with xylenol orange in an acidic medium. The color intensity, which could be measured spectrophotometrically, was related to the total amount of oxidant molecules present in the sample. The assay was calibrated with hydrogen peroxide and the results were expressed in terms of micromolar hydrogen peroxide equivalent per liter ( mmol H2O2 equivalent/L).
Determination of oxidative stress index The ratio of TOS to TAC was accepted as the oxidative stress index (OSI). For calculation, the resulting unit of TAC was changed to mmol/L, and the OSI value was calculated according to the following formula[16]: OSI (arbitrary unit) = TOS ( mmol H2O2 equivalent/L)/TAC (mmol Trolox equivalent/L).
Insulin resistance The insulin resistance index was calculated on the basis of fasting values for glycaemia and insulinemia, according to the homeostasis model assessment (HOMA)[17]: insulin resistance (HOMA-IR) = fasting insulinaemia ( mU/mL) × fasting glycaemia (mmol/L)/22.5.
Statistical analysis All data were expressed as mean ± SD. Comparisons of parameters were performed with Student’s t test and correlation analyses were performed using Pearson correlation test. P < 0.05 was considered statistically significant. Statistical analyses were performed by SPSS 11 statistical package.
RESULTS Demographic charesteristic of the subjects are shown in Table 1. There were no statistically significant differences between the two groups with regard to age, gender, and body mass indexi (BMI) and glucose level (P > 0.05) (Table 1). Insulin and insulin resistance levels were significantly higher in H pylori positive group than in H pylori negative group (P < 0.001) (Table 1).
Table 1 Demographic and clinical data of H pylori positive and negative groups (mean ± SD)
TAC level was significantly lower in the patients H pylori positive group than in H pylori negative group (P < 0.001), while TOS level and OSI value were significantly higher in H pylori positive group than in H pylori negative group (P < 0.001) (Table 2).
Table 2 Oxidative and antioxidative parameters in H pylori positive and negative groups (mean ± SD)
In Pearson correlation analysis, IR was found to be significantly correlated with TAC (r = -0.251, P < 0.05), TOS (r = 0.365, P < 0.05), and OSI (r = 0.267, P < 0.05).
DISCUSSION
Information about
the association of insulin resistance with H pylori infection
is scarecrly available[10,11]. Aydemir To our knowledge, the association of oxidative stress with insulin resistance in H pylori infection has not been investigated previously. We found a significant association between increased oxidative stress and insulin resistance in H pylori infection. It has been reported that H pylori infection is associated with increased tissue and systemic oxidative stress[18]. Moreover, oxidative stress has been proposed as the root cause for the development of insulin resistance, B-cell dysfunction, impaired glucose tolerance and type 2 diabetes mellitus[19]. In addition, various antioxidants such as vitamin E, alpha-lipoic acid, and N-acetylcysteine have been shown to have improving impact on insulin resistance[20-22]. Thus, the association of insulin resistance with H pylori infection observed in our study seems to be due to oxidative stress induced by H pylori. Many studies indicate that there are evident altera-tions in gastrointestinal hormone levels in H pylori infection[10,23-27]. H pylori infection has been found to decrease the expression of antral somatostation and to increase the release of acid-stimulating hormone gastrin[23]. Gastrin can inhibit glucose absorption in the small intestine[24] and amplify glucose-stimulated insulin release[25]. A link beween H pylori infection, serum gastrin, insulin and serum glucose concentrations has been demonstrated in dyspeptic patients[26]. During oral glucose ingestion, gastrin probably contributes very little to the insulin release. Gastrin may significantly stimulate the insulin secretion after protein-rich meals. Ordinary meal could stmulate immediate release of endogenous gastrin. The rise in serum gastrin is acute, preceding the increase in insulin concentrations[25]. Somatostatin regulates pancreatic insulin secretion and has an inhibitory effect on insulin release[10,26,27]. Decreased somatostation and increased gastrin hormone levels in patients with H pylori infection may play a role in the development of insulin resistance. However, in the present study, since we did not investigate gut hormones except for insulin, we could not provide any information related to this topic. In conclusion, our findings suggest that insulin resistance seems to be associated with increased oxidative stress in H pylori infection. Further studies are needed to clarify the mechanisms underlying this association and elucidate the effect of adding antioxidant vitamins to H pylori eradication therapy on insulin resistance during H pylori infection.
REFERENCES 1 Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med 2002; 33: 323-336 PubMed 2 Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 1999; 13 Suppl 1: 13-18 PubMed 3 Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, Rampton DS. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994; 29: 419-424 PubMed 4 Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996; 56: 3238-3243 PubMed 5 Baik SC, Youn HS, Chung MH, Lee WK, Cho MJ, Ko GH, Park CK, Kasai H, Rhee KH. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996; 56: 1279-1282 PubMed 6 Bagchi D, Bhattacharya G, Stohs SJ. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 1996; 24: 439-450 PubMed 7 Leontiadis GI, Sharma VK, Howden CW. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 1999; 159: 925-940 PubMed 8 Moller DE, Flier JS. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938-948 PubMed 9 Gasbarrini A, Ojetti V, Pitocco D, De Luca A, Franceschi F, Candelli M, Sanz Torre E, Pola P, Ghirlanda G, Gasbarrini G. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 1998; 10: 469-472 PubMed 10 Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, Gun BD, Borazan A, Ustundag Y. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 2005; 50: 2090-2093 PubMed 11 Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Kim BI, Keum DK. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc 2005; 97: 508-513 PubMed 12 Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004; 96: 1470-1476 PubMed 13 Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181 PubMed 14 Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119 PubMed 15 Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111 PubMed 16 Horoz M, Bolukbas C, Bolukbas FF, Aslan M, Koylu AO, Selek S, Erel O. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis 2006; 6: 114 PubMed 17 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419 PubMed 18 Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Aksoy N, Celik H, Erel O. Serum prolidase activity and oxidative status in Helicobacter pylori infection. Clin Biochem 2006 PubMed 19 Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006; 60: 308-314 PubMed 20 Shin MJ, Park E, Lee JH, Chung N. Relationship between insulin resistance and lipid peroxidation and antioxidant vitamins in hypercholesterolemic patients. Ann Nutr Metab 2006; 50: 115-120 PubMed 21 Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005; 7: 1040-1052 PubMed 22 Vinayaga Moorthi R, Bobby Z, Selvaraj N, Sridhar MG. Vitamin E protects the insulin sensitivity and redox balance in rat L6 muscle cells exposed to oxidative stress. Clin Chim Acta 2006; 367: 132-136 PubMed 23 Kaneko H, Konagaya T, Kusugami K. Helicobacter pylori and gut hormones. J Gastroenterol 2002; 37: 77-86 PubMed 24 Davenport HW. Physiology of the digestive tract. Chicago: Year Book Medical Publishers Inc, 1977 25 Rehfeld JF, Stadil F. The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest 1973; 52: 1415-1426 PubMed 26 Acbay O, Celik AF, Gundogdu S. Does Helicobacter pylori-induced gastritis enhance food-stimulated insulin release? Dig Dis Sci 1996; 41: 1327-1331 PubMed 27 Colturi TJ, Unger RH, Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest 1984; 74: 417-423 PubMed
S- Editor Wang J L- Editor Wang XL E- Editor Ma WH
|
|
|
|
|
PubMed